Skip to main content
User menu
Subscribe
Donate
The HIV Treatment Journal of
Webinars
Current Issue
Drug Guides
Trending
COVID-19 and HIV
HIV Decriminalization
Hepatitis C
U=U
HIV & Aging
HIV Basics
HIV Cure Research
HIV Prevention
HIV Treatment
Stigma & Discrimination
POZ Advocate
Archive
About
Who We Are
Advertise
Contact
Subscribe
Reader/Customer Service
News
Donate
Donate
Bulk Subscriber Donation
Search
10 Years of the U=U campaign: Where it’s succeeded—and fallen short
Being Bridgette: Community and clinicians meet
Biktarvy is among the 15 drugs facing Medicare price negotiations
Back to top
Search
Is a game-changing HIV prevention drug meeting global demand?
Lawsuit seeks to block Trump administration’s Ryan White restrictions on…
Texas HIV medication program stable for now, but funding concerns on the horizon
10 HIV activists arrested on Capitol Hill in protest against PEPFAR cuts
New Florida budget reverses cuts to ADAP
Missouri suspends Ryan White Part B services
Being Bridgette: Community and clinicians meet
Today’s chemsex pandemic requires novel approaches
How antibodies and T cells could keep HIV in check—without ART
The state of PrEP worldwide and new strategies for uptake
Pagination
First page
« First
Previous page
‹‹
…
Page
3
Current page
4
Page
5
Page
6
…
Next page
››
Last page
Last »
